Pharmaceuticals output up 21%

Biomedical manufacturing output expanded 19.5% in December.

The Singapore Economic Development Board reported:

Output of the biomedical manufacturing cluster expanded 19.5% in December 2012 compared to the same period a year ago.

The pharmaceuticals segment climbed 21.0%, mainly due to a different mix of active pharmaceutical ingredients being produced.

Robust export demand for medical devices drove the medical technology segment to record a gain of 11.8%.

On a year-to-date basis, output of the biomedical manufacturing cluster increased 9.9%, compared to the same period a year ago.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia